NDC 71288-816 – Yusimry

Adalimumab 40 mg/.8mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC71288-816

Product details

Brand name
Yusimry
Generic name
Adalimumab-aqvh
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761216
Marketed since
July 1, 2023
Listing expires
December 31, 2027
Pharmacologic class
Tumor Necrosis Factor Blocker

Active ingredients

Uses, dosage, side effects and warnings for Yusimry →

Package NDC codes (1)

Package NDCDescriptionSince
71288-816-812 SYRINGE, GLASS in 1 CARTON (71288-816-81) / .8 mL in 1 SYRINGE, GLASSJul 1, 2023

Other Yusimry products